Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Files for Resale of $600M in 2.5 Percent Convertible Notes

NEW YORK (GenomeWeb News) - Beckman Coulter has filed a registration statement with the US Securities and Exchange Commission for the resale of $600 million in 2.5 percent convertible senior notes due 2036. The registration allows holders to resell the securities with certain conditions.
 
The company said it will not receive any proceeds from the resale of the securities by the selling holders.
 
Beckman issued the notes in December 2006. At the time, it said it planned to use the funds to pay outstanding debts and to fund R&D projects.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.